Thymosin Alpha-1
Overview
Thymosin Alpha-1 is a synthetic peptide derived from thymic hormones, known for its immune-modulating properties. It offers a promising approach for researchers studying immune function, infectious diseases, and cancer, with potential applications in immunotherapy and vaccine development. Its ability to enhance T-cell function makes it a valuable tool for immunological research.
Detailed Benefits Analysis
- Immune Enhancement: Boosts T-cell maturation and activity, enhancing immune response. Clinical trials show improved outcomes in infections and cancer.
- Antiviral Activity: Exhibits antiviral effects against hepatitis B and C. Studies indicate reduced viral load.
- Cancer Therapy: Enhances antitumor immunity by activating dendritic cells and NK cells. Research in melanoma and lung cancer shows potential as an adjuvant therapy.
- Anti-Inflammatory Effects: Modulates inflammation by balancing pro- and anti-inflammatory cytokines. Preclinical data suggest potential in autoimmune disorder research.
Important Note
This product is for research purposes only and should not be used for human consumption. It’s not intended to diagnose, treat, or prevent any disease, and always follow local laws when handling research chemicals.
Structure
- Sequence: Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn
- Molecular Formula: C129H215N33O55
- Molecular Weight: 3108.28 g/mol
- PubChem CID: 16130571
Loading...